Revenue: The sum of all revenue fields included for a company's operating activities.
CASI Pharmaceuticals Inc. (CASIF) had Revenue of $20.71M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$20.71M |
$-48.06M |
|
$10.64M |
|
$10.08M |
|
$63.56M |
|
$-42.85M |
|
$-3.02M |
|
$-45.87M |
|
$-45.87M |
|
$-45.87M |
|
$-48.06M |
|
$-48.06M |
|
$-45.87M |
|
$-42.85M |
|
$-41.59M |
|
18.54M |
|
18.54M |
|
$-2.59 |
|
$-2.59 |
|
| Balance Sheet Financials | |
$13.46M |
|
$6.97M |
|
$12.19M |
|
$25.65M |
|
$49.67M |
|
-- |
|
$13.26M |
|
$62.93M |
|
$-37.28M |
|
$-37.50M |
|
$-37.28M |
|
20.56M |
|
| Cash Flow Statement Financials | |
$-20.75M |
|
$0.95M |
|
$11.25M |
|
$13.47M |
|
$5.63M |
|
$-7.84M |
|
$2.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.27 |
|
-- |
|
-- |
|
-- |
|
-0.63 |
|
48.65% |
|
-206.87% |
|
-206.87% |
|
-200.80% |
|
-221.47% |
|
-232.03% |
|
$-20.77M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
6.66 |
|
5.06 |
|
72.11 |
|
128.90% |
|
128.14% |
|
-187.36% |
|
128.90% |
|
$-1.81 |
|
$-1.12 |
|
$-1.12 |
|